ABDEL HADI, Nadine; BOET, Emeline; LAHALLE, Airelle; LAUTURE, Laura; REFEYTON, Alice; REYES-CASTELLANOS, Gabriela; CAPLET, Nathalie; CARRIER, Alice; LE CAM, Laurent; MAZURE, Nathalie M; RICCI, Jean-Ehrland; ROCCHI, Stephane; SARRY, Jean-Emmanuel; VASSEUR, Sophie; VLASKI-LAFARGE, Marija; ROSSIGNOL, Rodrigue; BOST, Frederic

doi:10.1111/febs.16295

Voir/Ouvrir

MRGM_The FEBS Journal_2022_Abdel Hadi.pdf (520.6Ko)

Métadonnées

Afficher la notice complète

Licence d’utilisation du document

ABDEL HADI, Nadine
Centre de Recherche en Cancérologie de Marseille [CRCM]

BOET, Emeline
Institut Universitaire du Cancer de Toulouse - Oncopole [IUCT Oncopole - UMR 1037]
Centre de Recherches en Cancérologie de Toulouse [CRCT]

LAHALLE, Airelle
Institut de Recherche en Cancérologie de Montpellier [IRCM - U1194 Inserm - UM]

Langue

Article de revue

Ce document a été publié dans

FEBS Journal. 2022-09-01, vol. 289, n° 18, p. 5516-5526

Résumé en anglais

The 4th International meeting Metabolism and Cancer initially programed to take place in Bordeaux (France) was held virtually on May 27-29, 2021. The three-day event was followed by around 600 participants daily from 47 countries around the world. The meeting hosted 21 speakers including selected talks and a keynote lecture from the Nobel Prize winner Sir Peter J. Ratcliffe (Oxford, UK). Presentations and discussions were divided in four scientific sessions: (a) Redox and energy metabolism (b) Redox and hypoxia (c) Metabolic profiling and epigenetic control and (d) Signalling, fuelling and metabolism in cancer and a general public session on cancer and nutrition. This report summarises the presentations and outcomes of the 4th annual Metabolism and Cancer symposium. We provide here a summary of the scientific highlights of this exciting meeting.< Réduire

Mots clés

Cancer

Epigenetics

Hypoxia

Metabolism

Mitochondria

Redox

Signaling